O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.02%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.37M
AUM Growth
+$5.37M
(-2.2%)
Cap. Flow
-$267K
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
153
New
13
Increased
31
Reduced
32
Closed
21
Top Buys
| 1 |
THRD
Third Harmonic Bio
THRD
|
$110K |
| 2 |
Sarepta Therapeutics
SRPT
|
$99.3K |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$50.1K |
| 4 |
Thermo Fisher Scientific
TMO
|
$45K |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$33.6K |
Top Sells
Sector Composition
| 1 | Healthcare | 98.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Evolent Health
EVH
$1.11B
| $71.7K | 1.33% |
1,994,717
+216,717
| +12% | +$7.79K |
|
27
Prelude Therapeutics
PRLD
$69.1M
| $66.4K | 1.23% |
10,039,691
| – | – |
|
28
Natera
NTRA
$23B
| $66K | 1.22% |
1,505,153
-156,200
| -9% | -$6.85K |
|
29
Keros Therapeutics
KROS
$640M
| $63.2K | 1.17% |
1,679,417
| – | – |
|
30
Crinetics Pharmaceuticals
CRNX
$3.26B
| $62.8K | 1.17% |
3,196,876
| – | – |
|
31
Mersana Therapeutics
MRSN
$34.8M
| $60.9K | 1.13% |
9,011,437
| – | – |
|
32
Biogen
BIIB
$20.8B
| $60K | 1.11% |
224,600
+113,000
| +101% | +$30.2K |
|
33
SI-BONE Inc
SIBN
$700M
| $58.8K | 1.09% |
3,368,000
| – | – |
|
|
VRNA
34
Verona Pharma
VRNA
$9.18B
| $58.2K | 1.08% |
5,694,841
| – | – |
|
35
Arcutis Biotherapeutics
ARQT
$1.91B
| $53.5K | 0.99% |
2,800,000
-1,981,646
| -41% | -$37.9K |
|
36
Guardant Health
GH
$8.11B
| $53.4K | 0.99% |
992,400
-41,000
| -4% | -$2.21K |
|
37
Xtant Medical Holdings
XTNT
$82.4M
| $52.6K | 0.98% |
73,114,592
+170,674
| +0.2% | +$123 |
|
|
38
Alnylam Pharmaceuticals
ALNY
$58.6B
| $50.1K | 0.93% |
+250,500
| New | +$50.1K |
|
39
Compass Therapeutics
CMPX
$466M
| $50.1K | 0.93% |
21,960,850
| – | – |
|
|
BLU
40
DELISTED
BELLUS Health Inc.
BLU
| $49K | 0.91% |
4,634,900
+3,180,100
| +219% | +$33.6K |
|
|
KNTE
41
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $48.3K | 0.9% |
4,043,629
| – | – |
|
42
Syndax Pharmaceuticals
SNDX
$1.39B
| $48.2K | 0.9% |
2,006,500
-316,800
| -14% | -$7.61K |
|
43
ARS Pharmaceuticals
SPRY
$1.08B
| $46.2K | 0.86% |
8,740,887
| – | – |
|
44
Terns Pharmaceuticals
TERN
$651M
| $44.1K | 0.82% |
7,481,204
+3,690,000
| +97% | +$21.7K |
|
45
Aclaris Therapeutics
ACRS
$223M
| $43.4K | 0.81% |
2,758,434
+432,934
| +19% | +$6.81K |
|
46
Progyny
PGNY
$2.02B
| $42K | 0.78% |
1,134,053
+509,053
| +81% | +$18.9K |
|
47
AbCellera Biologics
ABCL
$1.19B
| $41.3K | 0.77% |
4,180,768
| – | – |
|
48
Xenon Pharmaceuticals
XENE
$2.99B
| $41.1K | 0.76% |
1,137,300
-191,900
| -14% | -$6.93K |
|
49
Repare Therapeutics
RPTX
$73.9M
| $40.3K | 0.75% |
3,322,488
| – | – |
|
|
KDNY
50
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $39.9K | 0.74% |
2,029,300
+133,000
| +7% | +$2.62K |
|